Jared Feldman

Jared Feldman joined Access Biotechnology in September 2026. Prior to Access, Jared was Associate Director of Business Development at Autobahn Labs, where he partnered with biopharma and academic founders to launch early-stage therapeutics companies. Previously, he worked on the Business Development team at Vir Biotechnology and at Adimab, where he discovered and optimized therapeutic antibodies. Jared earned his PhD in Virology from Harvard University, where he studied antiviral B-cell responses, and his BS in Biochemistry from Bowdoin College.